Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
3.220
+0.110 (3.54%)
At close: Nov 4, 2024, 4:00 PM
3.140
-0.080 (-2.48%)
After-hours: Nov 4, 2024, 4:01 PM EST
Vistagen Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 4, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Market Capitalization | 87 | 143 | 27 | 256 | 305 | 22 | |
| Market Cap Growth | 538.84% | 421.73% | -89.32% | -16.12% | 1309.99% | -60.31% | |
| Enterprise Value | -19 | 18 | 5 | 176 | 211 | 29 | |
| Last Close Price | 3.22 | 5.28 | 3.74 | 37.20 | 63.90 | 13.20 | |
| PE Ratio | - | -3.47 | -0.44 | -5.04 | -4.34 | -0.88 | |
| PS Ratio | 83.47 | 134.11 | -120.48 | 230.94 | 280.23 | - | |
| PB Ratio | 0.83 | 1.25 | 2.26 | 3.96 | 3.11 | -30.18 | |
| P/FCF Ratio | -3.25 | -5.51 | -0.55 | -5.63 | -24.72 | -1.37 | |
| P/OCF Ratio | -3.27 | -5.53 | -0.55 | -5.66 | -25.29 | -1.37 | |
| EV/Sales Ratio | -23.69 | 17.28 | -24.05 | 158.30 | 193.50 | - | |
| EV/EBITDA Ratio | 0.60 | -0.56 | -0.09 | -3.69 | -11.83 | -1.42 | |
| EV/EBIT Ratio | 0.60 | -0.56 | -0.09 | -3.67 | -11.76 | -1.42 | |
| EV/FCF Ratio | 0.80 | -0.71 | -0.11 | -3.86 | -17.07 | -1.87 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.22 | 0.05 | 0.04 | -5.70 | |
| Debt / FCF Ratio | -0.07 | -0.08 | -0.05 | -0.07 | -0.30 | -0.26 | |
| Asset Turnover | 0.02 | 0.01 | - | 0.01 | 0.02 | - | |
| Quick Ratio | 17.38 | 23.26 | 3.64 | 11.88 | 24.62 | 0.49 | |
| Current Ratio | 17.77 | 23.55 | 3.83 | 12.32 | 24.85 | 0.57 | |
| Return on Equity (ROE) | -59.46% | -46.47% | -154.30% | -58.62% | -36.78% | -411.13% | |
| Return on Assets (ROA) | -37.09% | -28.52% | -77.39% | -32.65% | -19.66% | -131.43% | |
| Return on Capital (ROIC) | -40.79% | -31.46% | -89.75% | -35.19% | -21.28% | -182.29% | |
| Earnings Yield | -38.10% | -20.58% | -216.63% | -18.65% | -5.87% | -95.94% | |
| FCF Yield | -33.17% | -18.13% | -182.55% | -17.75% | -4.04% | -72.77% | |
| Buyback Yield / Dilution | -255.96% | -178.13% | -5.45% | -129.85% | -96.34% | -53.59% | |
| Total Shareholder Return | -255.96% | -178.13% | -5.45% | -129.85% | -96.34% | -53.59% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.